Dual Therapy in Inflammatory Bowel Disease.
Gabriele Altieri1,2, Alessandra Zilli1, Tommaso Lorenzo Parigi2
1Gastroenterology and Endoscopy, IRCCS San Raffaele Hospital, 20132 Milan, Italy.
Dual-targeted therapy (DTT) offers a promising approach for difficult-to-treat inflammatory bowel diseases (IBD). Combining treatments shows potential for improved outcomes in ulcerative colitis and Crohn's disease patients.
Area of Science:
- Gastroenterology and Immunology
- Pharmacology and Therapeutics
Background:
- Inflammatory bowel diseases (IBD), including ulcerative colitis (UC) and Crohn's disease (CD), are chronic autoimmune conditions with persistent treatment challenges.
- The therapeutic ceiling for existing treatments necessitates novel strategies for difficult-to-treat IBD cases.
Purpose of the Study:
- To review the efficacy and safety of dual-targeted therapy (DTT) in managing inflammatory bowel diseases.
- To explore DTT as a novel approach for patients with refractory IBD or extraintestinal manifestations.
Main Methods:
- Systematic review of clinical trials, systematic reviews, and real-world studies on DTT in IBD.
- Analysis of data focusing on clinical and endoscopic outcomes, as well as safety profiles.
Main Results:
- Dual-targeted therapy (DTT) demonstrates potential for improved clinical and endoscopic outcomes in IBD patients.
- Safety data for DTT are generally consistent with monotherapy, emphasizing the need for careful monitoring.
Conclusions:
- DTT represents a promising strategy for addressing unmet needs in difficult-to-treat inflammatory bowel diseases.
- Further research and high-quality trials are essential to optimize DTT regimens and expand its clinical use.
More Related Videos
08:58Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
08:27Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease
Published on: September 20, 2018
Related Concept Videos
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
